Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Other Financing Activities
Financing cash flows not reported separately.
Other Financing Activities history
Currency unavailable · from the cash flow
No Other Financing Activities data reported for this period type.
Other Financing Activities vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 24.55M SEK | -48.9% | +23.7% | 1846.2% |
| LTM Mar 2026 | $12.31M USD | -1095.5% | +476.7% | 3.4% | |
| LTM Mar 2026 | $284K USD | -115.8% | — | 0.2% | |
| LTM Jun 2026 | $0 USD | -100.0% | — | 0.0% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -107.9% | +250.2% | 1.8% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.